As the tenth most common cancer in the world, scientists are working hard to deliver treatments to alleviate the impact of bladder cancer on patients
The current standard of treatment for these patients includes a high-burden version of chemotherapy, followed by radical cystectomy. On top of that, the bladder permeability barrier often makes it difficult for medications to make their way to the tumor. This podcast — provided by Janssen — explains how innovative technologies within the field are changing that.
Check out the podcast episodes below.
⬆- Ep. 5 Changing the Treatment Paradigm for Patients
- Ep. 4 The Importance and Challenges of Early Diagnosis
- Ep. 3 The Transformation of Bladder Cancer Treatments and Role of Genetic Alterations
- Ep. 2 A Clinician's Journey Pt. II
- Ep. 1 A Clinician's Journey Pt. I
Ep. 5
Changing the Treatment Paradigm for Patients
In the final episode of Breaking Down Barriers, we highlight the second part of our conversation with Dr. Sam Spigelman. In the last episode, he spoke about the critical importance of early diagnosis when effectively treating bladder cancer and provided some education that can help clinicians and patients navigate diagnosis and treatment. Hear him touch on potentially transformative advances in bladder cancer diagnosis and treatment, discuss why innovation in bladder cancer treatments has been limited and how that is changing now, and talk about genetic alterations, systemic toxicities and why avoiding bladder surgery and removal is so important.
Ep. 4
The Importance and Challenges of Early Diagnosis
In this fourth podcast episode of Breaking Down Barriers, Dr. Sam Spigelman, M.D., Senior Global Medical Affairs Leader at Janssen Research & Development, LLC, helps shed light on the importance of early diagnosis and treatment in bladder cancer and innovations needed for therapies in early-stage bladder cancer. Tune in to listen to Dr. Spigelman explain the benefits of diagnosing bladder cancer at the early, organ-confined stage, the challenges of early diagnosis, and the impact of bladder removal on a patient’s well-being.
Ep. 3
The Transformation of Bladder Cancer Treatments and Role of Genetic Alterations
In the third episode of Breaking Down Barriers, Dr. Pat Keegan, Senior Medical Director for Janssen Research & Development, discusses the different types of bladder cancer and the importance of genetic testing when determining treatment options.
Ep. 2
A Clinician’s Journey Pt. II
In Episode 2 of Breaking Down Barriers, we take a look at the recent research breakthroughs happening at Janssen Oncology. Hear Dr. Christopher Cutie, bladder cancer researcher and the disease area leader of bladder cancer at Janssen, discuss these breakthroughs and how they have the potential to transform bladder cancer treatment and improve the lives of patients.
Ep. 1
A Clinician’s Journey Pt. I
In this inaugural episode of Breaking Down Barriers, Dr. Christopher Cutie opens up about his personal experience working with bladder cancer patients and the motivation behind dedicating his life to improving bladder cancer treatments.
